These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

905 related articles for article (PubMed ID: 29049853)

  • 41. Chemical approaches to study O-GlcNAcylation.
    Banerjee PS; Hart GW; Cho JW
    Chem Soc Rev; 2013 May; 42(10):4345-57. PubMed ID: 23247267
    [TBL] [Abstract][Full Text] [Related]  

  • 42. Catalytic Promiscuity of O-GlcNAc Transferase Enables Unexpected Metabolic Engineering of Cytoplasmic Proteins with 2-Azido-2-deoxy-glucose.
    Shen DL; Liu TW; Zandberg W; Clark T; Eskandari R; Alteen MG; Tan HY; Zhu Y; Cecioni S; Vocadlo D
    ACS Chem Biol; 2017 Jan; 12(1):206-213. PubMed ID: 27935279
    [TBL] [Abstract][Full Text] [Related]  

  • 43. Intracellular protein O-GlcNAc modification integrates nutrient status with transcriptional and metabolic regulation.
    Nagel AK; Ball LE
    Adv Cancer Res; 2015; 126():137-66. PubMed ID: 25727147
    [TBL] [Abstract][Full Text] [Related]  

  • 44. Chemical and Biochemical Strategies To Explore the Substrate Recognition of O-GlcNAc-Cycling Enzymes.
    Hu CW; Worth M; Li H; Jiang J
    Chembiochem; 2019 Feb; 20(3):312-318. PubMed ID: 30199580
    [TBL] [Abstract][Full Text] [Related]  

  • 45. O-linked-N-acetylglucosamine cycling and insulin signaling are required for the glucose stress response in Caenorhabditis elegans.
    Mondoux MA; Love DC; Ghosh SK; Fukushige T; Bond M; Weerasinghe GR; Hanover JA; Krause MW
    Genetics; 2011 Jun; 188(2):369-82. PubMed ID: 21441213
    [TBL] [Abstract][Full Text] [Related]  

  • 46. O-linked-N-acetylglucosamine on extracellular protein domains mediates epithelial cell-matrix interactions.
    Sakaidani Y; Nomura T; Matsuura A; Ito M; Suzuki E; Murakami K; Nadano D; Matsuda T; Furukawa K; Okajima T
    Nat Commun; 2011 Dec; 2():583. PubMed ID: 22158438
    [TBL] [Abstract][Full Text] [Related]  

  • 47. Glycan-dependent signaling: O-linked N-acetylglucosamine.
    Hanover JA
    FASEB J; 2001 Sep; 15(11):1865-76. PubMed ID: 11532966
    [TBL] [Abstract][Full Text] [Related]  

  • 48. N-acetylglucosamine modification in the lumen of the endoplasmic reticulum.
    Ogawa M; Sawaguchi S; Furukawa K; Okajima T
    Biochim Biophys Acta; 2015 Jun; 1850(6):1319-24. PubMed ID: 25791024
    [TBL] [Abstract][Full Text] [Related]  

  • 49. The Beginner's Guide to
    Mannino MP; Hart GW
    Front Immunol; 2022; 13():828648. PubMed ID: 35173739
    [TBL] [Abstract][Full Text] [Related]  

  • 50. O-GlcNAc transferase inhibitors: current tools and future challenges.
    Trapannone R; Rafie K; van Aalten DM
    Biochem Soc Trans; 2016 Feb; 44(1):88-93. PubMed ID: 26862193
    [TBL] [Abstract][Full Text] [Related]  

  • 51. Targeting the hexosamine biosynthetic pathway and O-linked N-acetylglucosamine cycling for therapeutic and imaging capabilities in diffuse large B-cell lymphoma.
    Pham LV; Bryant JL; Mendez R; Chen J; Tamayo AT; Xu-Monette ZY; Young KH; Manyam GC; Yang D; Medeiros LJ; Ford RJ
    Oncotarget; 2016 Dec; 7(49):80599-80611. PubMed ID: 27716624
    [TBL] [Abstract][Full Text] [Related]  

  • 52. Cytosolic O-glycosylation is abundant in nerve terminals.
    Cole RN; Hart GW
    J Neurochem; 2001 Dec; 79(5):1080-9. PubMed ID: 11739622
    [TBL] [Abstract][Full Text] [Related]  

  • 53. O-GlcNAc Modification Protects against Protein Misfolding and Aggregation in Neurodegenerative Disease.
    Ryan P; Xu M; Davey AK; Danon JJ; Mellick GD; Kassiou M; Rudrawar S
    ACS Chem Neurosci; 2019 May; 10(5):2209-2221. PubMed ID: 30985105
    [TBL] [Abstract][Full Text] [Related]  

  • 54. OGT: a short overview of an enzyme standing out from usual glycosyltransferases.
    Aquino-Gil M; Pierce A; Perez-Cervera Y; Zenteno E; Lefebvre T
    Biochem Soc Trans; 2017 Apr; 45(2):365-370. PubMed ID: 28408476
    [No Abstract]   [Full Text] [Related]  

  • 55. O-GlcNAc cycling: emerging roles in development and epigenetics.
    Love DC; Krause MW; Hanover JA
    Semin Cell Dev Biol; 2010 Aug; 21(6):646-54. PubMed ID: 20488252
    [TBL] [Abstract][Full Text] [Related]  

  • 56. Elevation of the post-translational modification of proteins by O-linked N-acetylglucosamine leads to deterioration of the glucose-stimulated insulin secretion in the pancreas of diabetic Goto-Kakizaki rats.
    Akimoto Y; Hart GW; Wells L; Vosseller K; Yamamoto K; Munetomo E; Ohara-Imaizumi M; Nishiwaki C; Nagamatsu S; Hirano H; Kawakami H
    Glycobiology; 2007 Feb; 17(2):127-40. PubMed ID: 17095531
    [TBL] [Abstract][Full Text] [Related]  

  • 57. O-GlcNAc and the epigenetic regulation of gene expression.
    Lewis BA; Hanover JA
    J Biol Chem; 2014 Dec; 289(50):34440-8. PubMed ID: 25336654
    [TBL] [Abstract][Full Text] [Related]  

  • 58. O-linked-N-acetylglucosamine modification of mammalian Notch receptors by an atypical O-GlcNAc transferase Eogt1.
    Sakaidani Y; Ichiyanagi N; Saito C; Nomura T; Ito M; Nishio Y; Nadano D; Matsuda T; Furukawa K; Okajima T
    Biochem Biophys Res Commun; 2012 Mar; 419(1):14-9. PubMed ID: 22310717
    [TBL] [Abstract][Full Text] [Related]  

  • 59. E. coli sabotages the in vivo production of O-linked β-N-acetylglucosamine-modified proteins.
    Goodwin OY; Thomasson MS; Lin AJ; Sweeney MM; Macnaughtan MA
    J Biotechnol; 2013 Dec; 168(4):315-23. PubMed ID: 24140293
    [TBL] [Abstract][Full Text] [Related]  

  • 60. Small Molecule-Activated
    Ge Y; Lu H; Yang B; Woo CM
    ACS Chem Biol; 2023 Jan; 18(1):193-201. PubMed ID: 36598936
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 46.